Share Price and Basic Stock Data
Last Updated: October 18, 2025, 8:46 pm
PEG Ratio | 0.00 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
HB Portfolio Ltd operates in the finance and investments sector, recording a market capitalization of ₹81.8 Cr and a share price of ₹76.00. The company has shown fluctuating revenue trends over recent quarters, with sales peaking at ₹37.32 Cr in March 2024 before declining to ₹28.26 Cr for the fiscal year ending March 2025. Quarterly sales in June 2023 stood at ₹4.85 Cr, rising to ₹5.88 Cr in September 2023, followed by a slight dip to ₹5.98 Cr in December 2023. This inconsistency in revenue generation raises concerns about the company’s operational stability. Furthermore, the trailing twelve months (TTM) sales are reported at ₹26.79 Cr, indicating a significant decline compared to earlier periods, such as ₹54.77 Cr in March 2024. The company’s ability to sustain growth in revenue remains critical, especially given that the finance sector typically expects stable income streams from investments and financial services.
Profitability and Efficiency Metrics
Profitability metrics for HB Portfolio Ltd reveal a challenging landscape, with a reported net profit of ₹-0.04 Cr for March 2025, contrasting sharply with ₹7.02 Cr in March 2024. The operating profit margin (OPM) stood at 46.88% for the most recent quarter, demonstrating some operational efficiency; however, the annual OPM declined to 10.83% for March 2025, indicating potential cost pressures. The interest coverage ratio (ICR) of 9.85x suggests that the company can comfortably meet its interest obligations, a positive sign amidst other profitability concerns. Additionally, the return on equity (ROE) is extremely low at 0.02%, reflecting inefficiencies in generating profit from shareholders’ equity. The cash conversion cycle (CCC) has stabilized at 13.69 days, suggesting improved operational liquidity, yet the overall profitability remains a pressing issue that the company needs to address to attract investor confidence.
Balance Sheet Strength and Financial Ratios
HB Portfolio Ltd’s balance sheet reveals a mix of strengths and weaknesses. The company holds reserves of ₹265.48 Cr against borrowings of just ₹1.06 Cr, indicating a robust capital structure with a low debt-to-equity ratio. This financial stability is further reinforced by a current ratio of 37.73, well above the typical sector benchmark, suggesting strong liquidity to cover short-term obligations. However, the book value per share has declined from ₹259.35 in March 2024 to ₹250.52 in March 2025, indicating a slight erosion of shareholder value. The price-to-book value (P/BV) ratio of 0.34x indicates that the stock is undervalued compared to its book value, which may be attractive to value investors. Nevertheless, the overall financial health is hampered by the low return on capital employed (ROCE) of 0.80%, reflecting inefficient use of capital in generating returns.
Shareholding Pattern and Investor Confidence
The shareholding pattern of HB Portfolio Ltd shows significant stability, with promoters holding 61.45% of the shares, ensuring a strong control over the company. Foreign institutional investors (FIIs) have minimal involvement, while domestic institutional investors (DIIs) hold only 0.02% of the shares, reflecting limited institutional interest. The public segment comprises 38.52% of the ownership, with the number of shareholders declining from 66,187 in September 2022 to 63,007 in March 2025. This reduction in shareholder count may signal waning investor confidence, especially given the company’s recent financial performance. The dividend payout ratio has been erratic, with an alarming figure of -2034.78% for March 2025, indicating that the company may not be prioritizing shareholder returns amidst profitability challenges. This combination of stable promoter ownership and declining public interest raises questions about future investor engagement and market perception.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies improve, HB Portfolio Ltd could potentially rebound from its current financial challenges. The company’s low debt levels and strong liquidity position provide a solid foundation for future growth, provided it can stabilize revenue and profitability metrics. However, the risks associated with fluctuating sales and declining net profits must be addressed to restore investor confidence. The reliance on a small group of promoters without significant institutional backing could also impact the company’s strategic direction and market perception. If the company can enhance its operational strategies and effectively manage costs, it may attract broader institutional interest, leading to a more favorable market sentiment. Ultimately, the path forward hinges on management’s ability to navigate these challenges while capitalizing on its existing strengths in financial stability and operational efficiency.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of HB Portfolio Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Modern Shares & Stockbrokers Ltd | 12.1 Cr. | 41.3 | 67.7/36.4 | 43.2 | 43.5 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
Monarch Networth Capital Ltd | 2,445 Cr. | 308 | 495/280 | 15.8 | 102 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
Multipurpose Trading & Agencies Ltd | 4.49 Cr. | 9.08 | 12.7/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
Munoth Financial Services Ltd | 24.4 Cr. | 47.6 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
Industry Average | 6,763.07 Cr | 1,429.69 | 132.51 | 3,769.18 | 0.31% | 21.70% | 14.20% | 7.28 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 5.49 | 3.84 | 10.69 | 2.49 | 4.85 | 5.88 | 5.98 | 37.32 | 8.75 | 5.06 | 9.73 | 4.30 | 7.70 |
Expenses | 2.98 | 2.48 | 8.90 | 4.20 | 3.26 | 3.06 | 3.18 | 36.61 | 3.93 | 4.81 | 10.29 | 6.16 | 4.09 |
Operating Profit | 2.51 | 1.36 | 1.79 | -1.71 | 1.59 | 2.82 | 2.80 | 0.71 | 4.82 | 0.25 | -0.56 | -1.86 | 3.61 |
OPM % | 45.72% | 35.42% | 16.74% | -68.67% | 32.78% | 47.96% | 46.82% | 1.90% | 55.09% | 4.94% | -5.76% | -43.26% | 46.88% |
Other Income | 0.01 | 0.01 | 0.01 | -0.01 | 0.21 | -0.00 | 0.08 | 0.72 | 0.11 | 0.14 | 0.09 | 0.11 | 0.05 |
Interest | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.10 | 0.04 | 0.04 | 0.21 | 0.02 | 0.02 |
Depreciation | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 | 0.11 | 0.09 | 0.47 | 0.17 | 0.17 | 0.18 | 0.30 | 0.21 |
Profit before tax | 2.41 | 1.26 | 1.69 | -1.82 | 1.67 | 2.69 | 2.77 | 0.86 | 4.72 | 0.18 | -0.86 | -2.07 | 3.43 |
Tax % | 8.30% | -9.52% | 2.96% | 26.37% | 33.53% | 25.28% | 42.96% | 43.02% | 30.51% | 216.67% | 19.77% | -12.56% | 37.90% |
Net Profit | 2.23 | 1.45 | 1.65 | -2.27 | 1.00 | 2.51 | 2.02 | 1.52 | 3.48 | 0.40 | -0.86 | -3.06 | 2.20 |
EPS in Rs | 2.06 | 1.35 | 1.53 | -2.11 | 0.92 | 2.33 | 1.88 | 1.41 | 3.22 | 0.37 | -0.80 | -2.84 | 2.03 |
Last Updated: August 19, 2025, 5:15 pm
Below is a detailed analysis of the quarterly data for HB Portfolio Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7.70 Cr.. The value appears strong and on an upward trend. It has increased from 4.30 Cr. (Mar 2025) to 7.70 Cr., marking an increase of 3.40 Cr..
- For Expenses, as of Jun 2025, the value is 4.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.16 Cr. (Mar 2025) to 4.09 Cr., marking a decrease of 2.07 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.61 Cr.. The value appears strong and on an upward trend. It has increased from -1.86 Cr. (Mar 2025) to 3.61 Cr., marking an increase of 5.47 Cr..
- For OPM %, as of Jun 2025, the value is 46.88%. The value appears strong and on an upward trend. It has increased from -43.26% (Mar 2025) to 46.88%, marking an increase of 90.14%.
- For Other Income, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.30 Cr. (Mar 2025) to 0.21 Cr., marking a decrease of 0.09 Cr..
- For Profit before tax, as of Jun 2025, the value is 3.43 Cr.. The value appears strong and on an upward trend. It has increased from -2.07 Cr. (Mar 2025) to 3.43 Cr., marking an increase of 5.50 Cr..
- For Tax %, as of Jun 2025, the value is 37.90%. The value appears to be increasing, which may not be favorable. It has increased from -12.56% (Mar 2025) to 37.90%, marking an increase of 50.46%.
- For Net Profit, as of Jun 2025, the value is 2.20 Cr.. The value appears strong and on an upward trend. It has increased from -3.06 Cr. (Mar 2025) to 2.20 Cr., marking an increase of 5.26 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.03. The value appears strong and on an upward trend. It has increased from -2.84 (Mar 2025) to 2.03, marking an increase of 4.87.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:09 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 8.38 | 3.04 | 2.24 | 3.31 | 31.52 | 14.10 | 14.61 | 21.47 | 18.57 | 23.06 | 54.77 | 28.26 | 26.79 |
Expenses | 1.79 | 1.82 | 2.05 | 2.85 | 17.20 | 16.95 | 19.68 | 16.44 | 11.47 | 19.10 | 46.10 | 25.20 | 25.35 |
Operating Profit | 6.59 | 1.22 | 0.19 | 0.46 | 14.32 | -2.85 | -5.07 | 5.03 | 7.10 | 3.96 | 8.67 | 3.06 | 1.44 |
OPM % | 78.64% | 40.13% | 8.48% | 13.90% | 45.43% | -20.21% | -34.70% | 23.43% | 38.23% | 17.17% | 15.83% | 10.83% | 5.38% |
Other Income | 0.14 | 0.06 | 0.01 | 0.01 | 0.27 | 1.04 | 0.10 | -0.01 | -0.01 | 0.04 | 0.26 | 0.03 | 0.39 |
Interest | 0.22 | 0.39 | 0.11 | 0.04 | 0.05 | 0.05 | 0.04 | 0.02 | 0.05 | 0.09 | 0.17 | 0.31 | 0.29 |
Depreciation | -0.01 | 0.19 | 0.07 | 0.06 | 0.30 | 0.28 | 0.27 | 0.28 | 0.31 | 0.36 | 0.79 | 0.83 | 0.86 |
Profit before tax | 6.52 | 0.70 | 0.02 | 0.37 | 14.24 | -2.14 | -5.28 | 4.72 | 6.73 | 3.55 | 7.97 | 1.95 | 0.68 |
Tax % | 23.16% | 51.43% | 550.00% | 24.32% | 18.61% | -0.93% | 1.52% | 6.78% | 6.69% | 16.90% | 35.26% | 89.74% | |
Net Profit | 1.34 | -4.31 | 6.46 | 3.16 | 11.66 | -2.74 | -5.31 | 4.52 | 6.46 | 3.06 | 7.02 | -0.04 | -1.32 |
EPS in Rs | 1.12 | -3.59 | 5.38 | 2.63 | 10.37 | -2.29 | -3.16 | 3.30 | 6.00 | 2.84 | 6.52 | -0.05 | -1.24 |
Dividend Payout % | 137.35% | -14.23% | 9.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 28.86% | 15.73% | -2,208.00% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -421.64% | 249.88% | -51.08% | 268.99% | -123.50% | -93.80% | 185.12% | 42.92% | -52.63% | 129.41% | -100.57% |
Change in YoY Net Profit Growth (%) | 0.00% | 671.53% | -300.97% | 320.07% | -392.49% | 29.70% | 278.92% | -142.20% | -95.55% | 182.04% | -229.98% |
HB Portfolio Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 25% |
5 Years: | 14% |
3 Years: | 15% |
TTM: | -54% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 15% |
3 Years: | % |
TTM: | -114% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 35% |
3 Years: | 30% |
1 Year: | -32% |
Return on Equity | |
---|---|
10 Years: | 2% |
5 Years: | 2% |
3 Years: | 1% |
Last Year: | 0% |
Last Updated: September 5, 2025, 3:41 pm
Balance Sheet
Last Updated: August 11, 2025, 4:10 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 12.27 | 12.27 | 12.27 | 12.27 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 |
Reserves | 113.48 | 108.45 | 114.18 | 117.35 | 128.08 | 144.27 | 115.19 | 143.43 | 194.18 | 181.14 | 274.83 | 265.48 |
Borrowings | 4.60 | 3.08 | 2.43 | 2.34 | 2.48 | 0.27 | 0.09 | 0.06 | 1.02 | 0.84 | 1.76 | 1.06 |
Other Liabilities | 8.83 | 9.57 | 4.95 | 5.47 | 27.87 | 27.04 | 25.04 | 9.06 | 10.34 | 2.77 | 13.97 | 11.54 |
Total Liabilities | 139.18 | 133.37 | 133.83 | 137.43 | 169.47 | 182.62 | 151.36 | 163.59 | 216.58 | 195.79 | 301.60 | 289.12 |
Fixed Assets | 0.51 | 0.33 | 0.28 | 0.23 | 2.49 | 0.82 | 0.82 | 0.63 | 1.91 | 1.67 | 2.49 | 1.95 |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 75.47 | 72.27 | 78.68 | 85.17 | 86.02 | 121.26 | 81.88 | 101.83 | 139.31 | 127.32 | 246.89 | 232.55 |
Other Assets | 63.20 | 60.77 | 54.87 | 52.03 | 80.96 | 60.54 | 68.66 | 61.13 | 75.36 | 66.80 | 52.22 | 54.62 |
Total Assets | 139.18 | 133.37 | 133.83 | 137.43 | 169.47 | 182.62 | 151.36 | 163.59 | 216.58 | 195.79 | 301.60 | 289.12 |
Below is a detailed analysis of the balance sheet data for HB Portfolio Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.04 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.04 Cr..
- For Reserves, as of Mar 2025, the value is 265.48 Cr.. The value appears to be declining and may need further review. It has decreased from 274.83 Cr. (Mar 2024) to 265.48 Cr., marking a decrease of 9.35 Cr..
- For Borrowings, as of Mar 2025, the value is 1.06 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1.76 Cr. (Mar 2024) to 1.06 Cr., marking a decrease of 0.70 Cr..
- For Other Liabilities, as of Mar 2025, the value is 11.54 Cr.. The value appears to be improving (decreasing). It has decreased from 13.97 Cr. (Mar 2024) to 11.54 Cr., marking a decrease of 2.43 Cr..
- For Total Liabilities, as of Mar 2025, the value is 289.12 Cr.. The value appears to be improving (decreasing). It has decreased from 301.60 Cr. (Mar 2024) to 289.12 Cr., marking a decrease of 12.48 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1.95 Cr.. The value appears to be declining and may need further review. It has decreased from 2.49 Cr. (Mar 2024) to 1.95 Cr., marking a decrease of 0.54 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 232.55 Cr.. The value appears to be declining and may need further review. It has decreased from 246.89 Cr. (Mar 2024) to 232.55 Cr., marking a decrease of 14.34 Cr..
- For Other Assets, as of Mar 2025, the value is 54.62 Cr.. The value appears strong and on an upward trend. It has increased from 52.22 Cr. (Mar 2024) to 54.62 Cr., marking an increase of 2.40 Cr..
- For Total Assets, as of Mar 2025, the value is 289.12 Cr.. The value appears to be declining and may need further review. It has decreased from 301.60 Cr. (Mar 2024) to 289.12 Cr., marking a decrease of 12.48 Cr..
Notably, the Reserves (265.48 Cr.) exceed the Borrowings (1.06 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 1.99 | -1.86 | -2.24 | -1.88 | 11.84 | -3.12 | -5.16 | 4.97 | 6.08 | 3.12 | 6.91 | 2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 43.12 | 0.00 | 0.00 | 0.00 | 10.89 | 18.12 | 4.75 | 13.26 | 18.08 | 12.03 | 35.65 | 13.69 |
Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 43.12 | 0.00 | 0.00 | 0.00 | 10.89 | 18.12 | 4.75 | 13.26 | 18.08 | 12.03 | 35.65 | 13.69 |
Working Capital Days | 1,802.35 | 4,740.20 | 6,627.03 | 4,053.60 | 651.37 | 267.15 | 239.84 | 158.95 | 147.42 | 126.31 | 210.19 | 342.91 |
ROCE % | 5.13% | 0.86% | 0.10% | 0.31% | 9.88% | -1.76% | -3.29% | 3.19% | 3.76% | 1.82% | 3.33% | 0.80% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | -0.04 | 4.80 | 2.73 | 5.83 | 4.09 |
Diluted EPS (Rs.) | -0.04 | 4.80 | 2.73 | 5.83 | 4.09 |
Cash EPS (Rs.) | 0.93 | 5.39 | 2.99 | 5.97 | 4.24 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 250.52 | 259.35 | 174.45 | 186.26 | 140.28 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 250.52 | 259.35 | 174.45 | 186.26 | 140.28 |
Revenue From Operations / Share (Rs.) | 25.22 | 48.95 | 20.89 | 16.82 | 19.45 |
PBDIT / Share (Rs.) | 2.81 | 8.09 | 3.60 | 6.41 | 4.54 |
PBIT / Share (Rs.) | 2.05 | 7.38 | 3.27 | 6.12 | 4.28 |
PBT / Share (Rs.) | 1.77 | 7.22 | 3.21 | 6.09 | 4.28 |
Net Profit / Share (Rs.) | 0.18 | 4.68 | 2.67 | 5.68 | 3.99 |
NP After MI And SOA / Share (Rs.) | -0.04 | 6.36 | 2.77 | 5.85 | 3.21 |
PBDIT Margin (%) | 11.12 | 16.52 | 17.22 | 38.07 | 23.33 |
PBIT Margin (%) | 8.14 | 15.06 | 15.65 | 36.39 | 22.01 |
PBT Margin (%) | 7.01 | 14.75 | 15.38 | 36.22 | 21.97 |
Net Profit Margin (%) | 0.74 | 9.56 | 12.76 | 33.79 | 20.49 |
NP After MI And SOA Margin (%) | -0.19 | 12.99 | 13.25 | 34.76 | 16.51 |
Return on Networth / Equity (%) | -0.01 | 2.45 | 1.59 | 3.14 | 2.29 |
Return on Capital Employeed (%) | 0.79 | 2.73 | 1.85 | 3.14 | 2.90 |
Return On Assets (%) | -0.01 | 2.32 | 1.56 | 2.98 | 2.16 |
Asset Turnover Ratio (%) | 0.09 | 0.21 | 0.11 | 0.01 | 0.04 |
Current Ratio (X) | 37.73 | 80.61 | 129.49 | 124.98 | 168.33 |
Quick Ratio (X) | 37.73 | 80.61 | 129.49 | 124.98 | 168.33 |
Dividend Payout Ratio (NP) (%) | -2034.78 | 15.32 | 28.17 | 0.00 | 0.00 |
Dividend Payout Ratio (CP) (%) | 138.60 | 13.78 | 25.19 | 0.00 | 0.00 |
Earning Retention Ratio (%) | 2134.78 | 84.68 | 71.83 | 0.00 | 0.00 |
Cash Earning Retention Ratio (%) | -38.60 | 86.22 | 74.81 | 0.00 | 0.00 |
Interest Coverage Ratio (X) | 9.85 | 52.12 | 63.65 | 222.25 | 688.04 |
Interest Coverage Ratio (Post Tax) (X) | 1.66 | 31.18 | 48.18 | 198.25 | 605.30 |
Enterprise Value (Cr.) | 89.11 | 57.65 | 30.47 | 23.12 | 16.30 |
EV / Net Operating Revenue (X) | 3.20 | 1.07 | 1.32 | 1.25 | 0.75 |
EV / EBITDA (X) | 28.78 | 6.46 | 7.67 | 3.27 | 3.25 |
MarketCap / Net Operating Revenue (X) | 3.43 | 1.23 | 1.80 | 1.96 | 0.97 |
Retention Ratios (%) | 2134.78 | 84.67 | 71.82 | 0.00 | 0.00 |
Price / BV (X) | 0.34 | 0.23 | 0.21 | 0.17 | 0.13 |
Price / Net Operating Revenue (X) | 3.43 | 1.23 | 1.80 | 1.96 | 0.97 |
EarningsYield | 0.00 | 0.10 | 0.07 | 0.17 | 0.16 |
After reviewing the key financial ratios for HB Portfolio Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 4.80 (Mar 24) to -0.04, marking a decrease of 4.84.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 4.80 (Mar 24) to -0.04, marking a decrease of 4.84.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 3. It has decreased from 5.39 (Mar 24) to 0.93, marking a decrease of 4.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 250.52. It has decreased from 259.35 (Mar 24) to 250.52, marking a decrease of 8.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 250.52. It has decreased from 259.35 (Mar 24) to 250.52, marking a decrease of 8.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 25.22. It has decreased from 48.95 (Mar 24) to 25.22, marking a decrease of 23.73.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.81. This value is within the healthy range. It has decreased from 8.09 (Mar 24) to 2.81, marking a decrease of 5.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.05. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 2.05, marking a decrease of 5.33.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 1.77, marking a decrease of 5.45.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 2. It has decreased from 4.68 (Mar 24) to 0.18, marking a decrease of 4.50.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 2. It has decreased from 6.36 (Mar 24) to -0.04, marking a decrease of 6.40.
- For PBDIT Margin (%), as of Mar 25, the value is 11.12. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 11.12, marking a decrease of 5.40.
- For PBIT Margin (%), as of Mar 25, the value is 8.14. This value is below the healthy minimum of 10. It has decreased from 15.06 (Mar 24) to 8.14, marking a decrease of 6.92.
- For PBT Margin (%), as of Mar 25, the value is 7.01. This value is below the healthy minimum of 10. It has decreased from 14.75 (Mar 24) to 7.01, marking a decrease of 7.74.
- For Net Profit Margin (%), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has decreased from 9.56 (Mar 24) to 0.74, marking a decrease of 8.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 8. It has decreased from 12.99 (Mar 24) to -0.19, marking a decrease of 13.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 15. It has decreased from 2.45 (Mar 24) to -0.01, marking a decrease of 2.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 10. It has decreased from 2.73 (Mar 24) to 0.79, marking a decrease of 1.94.
- For Return On Assets (%), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to -0.01, marking a decrease of 2.33.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. It has decreased from 0.21 (Mar 24) to 0.09, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 37.73. This value exceeds the healthy maximum of 3. It has decreased from 80.61 (Mar 24) to 37.73, marking a decrease of 42.88.
- For Quick Ratio (X), as of Mar 25, the value is 37.73. This value exceeds the healthy maximum of 2. It has decreased from 80.61 (Mar 24) to 37.73, marking a decrease of 42.88.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -2,034.78. This value is below the healthy minimum of 20. It has decreased from 15.32 (Mar 24) to -2,034.78, marking a decrease of 2,050.10.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 138.60. This value exceeds the healthy maximum of 50. It has increased from 13.78 (Mar 24) to 138.60, marking an increase of 124.82.
- For Earning Retention Ratio (%), as of Mar 25, the value is 2,134.78. This value exceeds the healthy maximum of 70. It has increased from 84.68 (Mar 24) to 2,134.78, marking an increase of 2,050.10.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -38.60. This value is below the healthy minimum of 40. It has decreased from 86.22 (Mar 24) to -38.60, marking a decrease of 124.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has decreased from 52.12 (Mar 24) to 9.85, marking a decrease of 42.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 3. It has decreased from 31.18 (Mar 24) to 1.66, marking a decrease of 29.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 89.11. It has increased from 57.65 (Mar 24) to 89.11, marking an increase of 31.46.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 3. It has increased from 1.07 (Mar 24) to 3.20, marking an increase of 2.13.
- For EV / EBITDA (X), as of Mar 25, the value is 28.78. This value exceeds the healthy maximum of 15. It has increased from 6.46 (Mar 24) to 28.78, marking an increase of 22.32.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 1.23 (Mar 24) to 3.43, marking an increase of 2.20.
- For Retention Ratios (%), as of Mar 25, the value is 2,134.78. This value exceeds the healthy maximum of 70. It has increased from 84.67 (Mar 24) to 2,134.78, marking an increase of 2,050.11.
- For Price / BV (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.34, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 1.23 (Mar 24) to 3.43, marking an increase of 2.20.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in HB Portfolio Ltd:
- Net Profit Margin: 0.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.79% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.01% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.66
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 37.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 132.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.74%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Finance & Investments | Plot No. 31, Gurgaon Haryana 122001 | corporate@hbportfolio.com http://www.hbportfolio.com |
Management | |
---|---|
Name | Position Held |
Mr. Lalit Bhasin | Chairman |
Mr. Anil Goyal | Managing Director |
Mrs. Anita Jain | Director |
Mr. Gurjot Singh Narang | Director |
Mr. Harbans Lal | Director |
FAQ
What is the intrinsic value of HB Portfolio Ltd?
HB Portfolio Ltd's intrinsic value (as of 19 October 2025) is 0.62 which is 99.18% lower the current market price of 75.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 81.3 Cr. market cap, FY2025-2026 high/low of 123/71.7, reserves of ₹265.48 Cr, and liabilities of 289.12 Cr.
What is the Market Cap of HB Portfolio Ltd?
The Market Cap of HB Portfolio Ltd is 81.3 Cr..
What is the current Stock Price of HB Portfolio Ltd as on 19 October 2025?
The current stock price of HB Portfolio Ltd as on 19 October 2025 is 75.5.
What is the High / Low of HB Portfolio Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of HB Portfolio Ltd stocks is 123/71.7.
What is the Stock P/E of HB Portfolio Ltd?
The Stock P/E of HB Portfolio Ltd is .
What is the Book Value of HB Portfolio Ltd?
The Book Value of HB Portfolio Ltd is 257.
What is the Dividend Yield of HB Portfolio Ltd?
The Dividend Yield of HB Portfolio Ltd is 1.32 %.
What is the ROCE of HB Portfolio Ltd?
The ROCE of HB Portfolio Ltd is 0.80 %.
What is the ROE of HB Portfolio Ltd?
The ROE of HB Portfolio Ltd is 0.02 %.
What is the Face Value of HB Portfolio Ltd?
The Face Value of HB Portfolio Ltd is 10.0.